Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer
Open Access
- 28 March 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 94 (8), 1130-1135
- https://doi.org/10.1038/sj.bjc.6603072
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Phase I Study of S-1 Combined with Irinotecan (CPT-11) in Patients with Advanced Gastric Cancer (OGSG 0002)Japanese Journal of Clinical Oncology, 2005
- Phase II Study of Oral S-1 Plus Irinotecan in Patients with Advanced Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302Japanese Journal of Clinical Oncology, 2005
- Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II studyAnnals of Oncology, 2004
- Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803Journal of Clinical Oncology, 2004
- Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancerInternational Journal of Clinical Oncology, 2003
- Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric CancerOncology, 2000
- Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patientsEuropean Journal Of Cancer, 1998
- Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulatorsAnti-Cancer Drugs, 1996
- Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerBritish Journal of Cancer, 1995
- Simultaneous Administration of CPT-11 and Fluorouracil: Alteration of the Pharmacokinetics of CPT-11 and SN-38 in Patients With Advanced Colorectal CancerJNCI Journal of the National Cancer Institute, 1994